Breast: Page 106

Ultrasound tomography helps characterize breast cancer
By Kate Madden Yee
Wednesday, December 4 | 12:45 p.m.-1:15 p.m. | BR278-SD-WEB5 | Lakeside, BR Community, Station 5In this poster presentation, researchers will discuss how ultrasound tomography is a feasible and accurate tool for characterizing stiffness of breast lesions.
November 10, 2019
2017 11 07 18 37 9362 Roadies Ribbon 400
Trust whole-breast US for supplemental breast cancer screening
By Kate Madden Yee
Wednesday, December 4 | 11:50 a.m.-12:00 p.m. | SSK02-09 | Room E450AWhole-breast ultrasound performed by a technologist is an effective way to provide adjuvant screening to women with dense breast tissue, according to research to be presented on Wednesday morning.
November 10, 2019
Breast ultrasound helpful supplement even after DBT
By Kate Madden Yee
Monday, December 2 | 3:50 p.m.-4:00 p.m. | SSE02-06 | Room E451BIn this session, University of Pittsburgh researchers will discuss how whole-breast ultrasound performed by a technologist can find more cancers in women with dense breast tissue even after screening digital breast tomosynthesis (DBT) -- although it does increase the recall rate.
November 10, 2019
Novel phantoms help evaluate ultrasound systems
By Kate Madden Yee
Monday, December 2 | 3:30 p.m.-3:40 p.m. | SSE22-04 | Room E352In this presentation, researchers will describe how breast phantoms can help in the evaluation of ultrasound systems and different image optimization controls.
November 10, 2019
Is supplemental whole-breast US needed after DBT?
By Kate Madden Yee
Monday, December 2 | 3:20 p.m.-3:30 p.m. | SSE02-03 | Room E451BDo women with dense breast tissue who have a normal digital breast tomosynthesis (DBT) exam need supplemental whole-breast ultrasound imaging? Perhaps not, according to research to be presented Monday afternoon.
November 10, 2019
Breast ultrasound useful for average-risk women
By Kate Madden Yee
Monday, December 2 | 3:10 p.m.-3:20 p.m. | SSE02-02 | Room E451BIn this scientific session, researchers will discuss how screening breast ultrasound is a useful supplement to mammography in women at average risk of breast cancer, not just those at high risk.
November 10, 2019
CADx for breast ultrasound comparable to radiologists
By Kate Madden Yee
Monday, December 2 | 12:45 p.m.-1:15 p.m. | BR254-SD-MOB4 | Lakeside, BR Community, Station 4Computer-assisted diagnosis (CADx) for breast ultrasound performs comparably to expert radiologists, according to study findings to be presented in this poster session on Monday afternoon.
November 10, 2019
RadNet forms partnership with AI developer
By AuntMinnie.com staff writers
Imaging services provider RadNet has signed a partnership with artificial intelligence (AI) developer Whiterabbit.ai to create and deploy AI algorithms for breast cancer imaging.
November 6, 2019
2019 02 19 18 03 9526 Mammogram Breast 400
Hologic finishes 2019 strong with accelerating sales
By AuntMinnie.com staff writers
Women's imaging vendor Hologic finished strong in its 2019 fiscal year, with the company's revenue accelerating in the fourth quarter at the highest rate of the year. However, charges related to its Cynosure medical aesthetics business pushed the company into the red for the year.
November 6, 2019
2019 02 01 17 54 2200 Hologic Rsna 2018 400
Life Image partners with Geisinger
By AuntMinnie.com staff writers
Medical image-sharing technology developer Life Image has formed a partnership with the Geisinger Health System.
November 5, 2019
2016 08 24 09 43 13 537 Hands Shaking V3 400
Why do so few women follow up on MRI-guided biopsies?
By Wayne Forrest
Friday, December 6 | 10:40 a.m.-10:50 a.m. | SST01-02 | Room E450AVery few women heed the recommendation to follow up a benign MRI-guided breast biopsy with an MRI scan six or 12 months later. The question is: What's stopping them?
November 5, 2019
Call on MRI-guided biopsy for breast cancer treatment response
By Wayne Forrest
Friday, December 6 | 10:30 a.m.-10:40 a.m. | SST01-01 | Room E450AMRI-guided biopsy is proficient at diagnosing a pathological complete response after neoadjuvant chemotherapy for breast cancer, according to this proof-of-concept clinical trial.
November 5, 2019
Previous Page
Page 106 of 574
Next Page